Hims & Hers Health (HIMS) Net Income (2019 - 2026)
Hims & Hers Health (HIMS) posted Net Income of -$92.1 million for Q1 2026, down 547.14% sequentially from $20.6 million in Q4 2025, and down 286.15% YoY from $49.5 million in Q1 2025.
Hims & Hers Health (HIMS) Net Income (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Net Income for 8 years, with the latest figure at -$92.1 million in Q1 2026.
- Quarterly Net Income fell 286.15% year-over-year to -$92.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.2 million (down 108.05% YoY) and the FY2025 annual result came in at $128.4 million, up 1.85% from the prior year.
- Net Income retreated to -$92.1 million in Q1 2026 per HIMS's latest filing, from $20.6 million in the prior quarter.
- Over five years, Net Income peaked at $75.6 million in Q3 2024 and troughed at -$92.1 million in Q1 2026.
- A 5-year average of $4.3 million and a median of $1.2 million in 2023 frame the typical range for Net Income.
- The sharpest annual moves came in 2024 and 2026: Net Income surged 1990.36% in 2024, then plunged 286.15% in 2026.
- Over 5 years, Net Income stood at -$10.9 million in 2022, then surged by 111.41% to $1.2 million in 2023, then soared by 1990.36% to $26.0 million in 2024, then retreated by 20.84% to $20.6 million in 2025, then sank by 547.14% to -$92.1 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$92.1 million, $20.6 million, and $15.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -69.36 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | -86.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -86.29 Mn |
| Mar 31, 2026 | -92.12 Mn |
| Dec 31, 2025 | 20.60 Mn |
| Sep 30, 2025 | 15.77 Mn |
| Jun 30, 2025 | 42.51 Mn |
| Mar 31, 2025 | 49.49 Mn |
| Dec 31, 2024 | 26.03 Mn |
| Sep 30, 2024 | 75.59 Mn |
| Jun 30, 2024 | 13.30 Mn |
| Mar 31, 2024 | 11.13 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | -7.57 Mn |
| Jun 30, 2023 | -7.16 Mn |
| Mar 31, 2023 | -10.07 Mn |
| Dec 31, 2022 | -10.91 Mn |
| Sep 30, 2022 | -18.84 Mn |
| Jun 30, 2022 | -19.68 Mn |
| Mar 31, 2022 | -16.25 Mn |
| Dec 31, 2021 | -31.16 Mn |
| Sep 30, 2021 | -15.94 Mn |